table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
Immunosuppressants drugs
anakinra SAVE-MORE CORIMUNO-ANA-1
anti-interleukin-6
sarilumab CORIMUNO-SARI-1 ...
tocilizumab EMPACTA NCT04412772 ... RECOVERY Declercq J ... RCT-TCZ-COVID-19 Soin AS ... NCT04577534 ... EU-CTR2020-001375-32 ... EU-CTR2020-001748-24 ... NCT04479358 ... Rutgers NCT04434717 ... Dongsheng Wang BACC Bay Tocilizumab Trial
canakinumab Sheng ...
janus kinase (JAK) inhibitor
baricitinib COV-BARRIER ACTT-2 ... RECOVERY
tofacitinib STOP-COVID ...
lenzilumab LIVE-AIR ...

0 studies excluded by filtering options 0

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons